GERON CORP Other Non-Current Assets
GERON CORP (GERN) had Other Non-Current Assets of $1.03 million as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2019-11-06
- 2019-09-30: Other Assets, Noncurrent $1.03M.
- 2019-06-30: Other Assets, Noncurrent $1.46M.
- 2019-03-31: Other Assets, Noncurrent $1.19M.
- 2018-12-31: Other Assets, Noncurrent $585.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2019-09-30 | $1.03M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.46M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.19M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $585.00K 10-Q · filed 2019-11-06 |
| 2018-09-30 | $851.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $676.00K 10-Q · filed 2018-07-31 |
| 2018-03-31 | $1.11M 10-Q · filed 2018-05-10 |
| 2018-01-01 | $1.19M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |